Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications

Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications

Item
http://www.wikidata.org/entity/Q28213716
Q28181435
sameAs
The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded.Glycosaminoglycan remodeling during diabetes and the role of dietary factors in their modulationMechanisms of islet amyloidosis toxicity in type 2 diabetesDiabetic nephropathy and extracellular matrixSulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathyAmyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit.Perlecan and tumor angiogenesis.Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions.Human immunodeficiency virus downregulates podocyte apoE expression.Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling.Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis.Heparanase is essential for the development of diabetic nephropathy in mice.Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1.Changes in the basal membrane of dorsal root ganglia Schwann cells explain the biphasic pattern of the peripheral neuropathy in streptozotocin-induced diabetic rats.Diabetes induces stromal remodelling and increase in chondroitin sulphate proteoglycans of the rat ventral prostate.Identification of iduronate-2-sulfatase in mouse pancreatic islets.MRT letter: application of novel "in vivo cryotechnique" in living animal kidneys.
P2860

Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications

Item
http://www.wikidata.org/entity/Q28213716
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Heparan sulfate proteoglycans ...... ecan in diabetes complications
@ast
Heparan sulfate proteoglycans ...... ecan in diabetes complications
@en
Heparan sulfate proteoglycans ...... ecan in diabetes complications
@nl
type
label
Heparan sulfate proteoglycans ...... ecan in diabetes complications
@ast
Heparan sulfate proteoglycans ...... ecan in diabetes complications
@en
Heparan sulfate proteoglycans ...... ecan in diabetes complications
@nl
prefLabel
Heparan sulfate proteoglycans ...... ecan in diabetes complications
@ast
Heparan sulfate proteoglycans ...... ecan in diabetes complications
@en
Heparan sulfate proteoglycans ...... ecan in diabetes complications
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Heparan sulfate proteoglycans ...... ecan in diabetes complications
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698